semaglutide clinical trials vs. Tirzepatide for Obesity The SELECT Trial - A
Description
Participants Adult patients with diabetes who were newly prescribed add-on non-insulin glucose-lowering agents and were on metformin between 2005-2020
Our GLP-1 injection program supports healthy weight loss by regulating appetite, improving blood sugar, and enhancing metabolism
A Clinical Hypothesis on Viral Gastroenteritis and Endogenous Incretin Response A curious observation comes up now and then in clinic: a patient with a viral GI illnesstypically marked by nausea, loss of appetite, and sometimes transient weight lossdescribes symptoms eerily similar to what we see
This treatment supports metabolic balance as part of a structured 3-month care plan under clinician supervision
Explore how GLP-1 therapies may impact dementia risk in diabetes care
